
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma, Miaojun Han, Bernd Heinrich, et al.
Science (2018) Vol. 360, Iss. 6391
Open Access | Times Cited: 1180
Chi Ma, Miaojun Han, Bernd Heinrich, et al.
Science (2018) Vol. 360, Iss. 6391
Open Access | Times Cited: 1180
Showing 1-25 of 1180 citing articles:
Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4472
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4472
Interaction between microbiota and immunity in health and disease
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Research (2020) Vol. 30, Iss. 6, pp. 492-506
Open Access | Times Cited: 2772
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Research (2020) Vol. 30, Iss. 6, pp. 492-506
Open Access | Times Cited: 2772
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1636
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1636
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1433
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1433
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1254
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1254
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 151-172
Closed Access | Times Cited: 1170
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 151-172
Closed Access | Times Cited: 1170
The microbiome, cancer, and cancer therapy
Beth A. Helmink, Md Abdul Wadud Khan, Amanda Hermann, et al.
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 377-388
Closed Access | Times Cited: 964
Beth A. Helmink, Md Abdul Wadud Khan, Amanda Hermann, et al.
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 377-388
Closed Access | Times Cited: 964
Bile acid metabolites control TH17 and Treg cell differentiation
Saiyu Hang, Donggi Paik, Lina Yao, et al.
Nature (2019) Vol. 576, Iss. 7785, pp. 143-148
Open Access | Times Cited: 959
Saiyu Hang, Donggi Paik, Lina Yao, et al.
Nature (2019) Vol. 576, Iss. 7785, pp. 143-148
Open Access | Times Cited: 959
Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer, Jing Fan, Fredrik Bäckhed
Nature Reviews Microbiology (2020) Vol. 19, Iss. 2, pp. 77-94
Closed Access | Times Cited: 906
Kimberly A. Krautkramer, Jing Fan, Fredrik Bäckhed
Nature Reviews Microbiology (2020) Vol. 19, Iss. 2, pp. 77-94
Closed Access | Times Cited: 906
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 878
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 878
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Gregory Poore, Evguenia Kopylova, Qiyun Zhu, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 567-574
Open Access | Times Cited: 860
Gregory Poore, Evguenia Kopylova, Qiyun Zhu, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 567-574
Open Access | Times Cited: 860
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu, Michael D. Green, Shasha Li, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 152-164
Open Access | Times Cited: 679
Jiali Yu, Michael D. Green, Shasha Li, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 152-164
Open Access | Times Cited: 679
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, et al.
Gut (2020) Vol. 70, Iss. 4, pp. 761-774
Open Access | Times Cited: 623
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, et al.
Gut (2020) Vol. 70, Iss. 4, pp. 761-774
Open Access | Times Cited: 623
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Yonghyun Lee, Kohei Sugihara, Merritt Gillilland, et al.
Nature Materials (2019) Vol. 19, Iss. 1, pp. 118-126
Open Access | Times Cited: 540
Yonghyun Lee, Kohei Sugihara, Merritt Gillilland, et al.
Nature Materials (2019) Vol. 19, Iss. 1, pp. 118-126
Open Access | Times Cited: 540
Microbial regulation of organismal energy homeostasis
Patrice D. Cani, Matthias Van Hul, Charlotte Lefort, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 34-46
Closed Access | Times Cited: 449
Patrice D. Cani, Matthias Van Hul, Charlotte Lefort, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 34-46
Closed Access | Times Cited: 449
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 442
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 442
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 362
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 362
Human gut bacteria produce ΤΗ17-modulating bile acid metabolites
Donggi Paik, Lina Yao, Yancong Zhang, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 907-912
Open Access | Times Cited: 360
Donggi Paik, Lina Yao, Yancong Zhang, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 907-912
Open Access | Times Cited: 360
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yoon Mee Yang, Sohee Kim, Ekihiro Seki
Seminars in Liver Disease (2019) Vol. 39, Iss. 01, pp. 026-042
Open Access | Times Cited: 341
Yoon Mee Yang, Sohee Kim, Ekihiro Seki
Seminars in Liver Disease (2019) Vol. 39, Iss. 01, pp. 026-042
Open Access | Times Cited: 341
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases
Wenjing Yang, Yingzi Cong
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 4, pp. 866-877
Open Access | Times Cited: 333
Wenjing Yang, Yingzi Cong
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 4, pp. 866-877
Open Access | Times Cited: 333
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 708-724.e11
Open Access | Times Cited: 330
Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 708-724.e11
Open Access | Times Cited: 330
A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity
David Wylensek, Thomas C. A. Hitch, Thomas Riedel, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 329
David Wylensek, Thomas C. A. Hitch, Thomas Riedel, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 329
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 321
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 321
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 320
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 320
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 320
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 320